Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • RESOURCES
    • About BJGP
    • Conference
      • Programme
    • Advertising
    • BJGP Blog
    • eLetters
    • Feedback
    • Librarian information
    • Alerts
    • Resilience
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • RESOURCES
    • About BJGP
    • Conference
    • Advertising
    • BJGP Blog
    • eLetters
    • Feedback
    • Librarian information
    • Alerts
    • Resilience
Debate & Analysis

Lower urinary tract symptoms and prostate cancer: is PSA testing in men with symptoms wise?

Jasmine Just, Fiona Osgun and Claire Knight
Br J Gen Pract 2018; 68 (676): 541-542. DOI: https://doi.org/10.3399/bjgp18X699689
Jasmine Just
Cancer Research UK, London.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona Osgun
Cancer Research UK, London.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Knight
Cancer Research UK, London.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info
  • eLetters
  • PDF
Loading

INTRODUCTION

The best evidence to date shows that, overall, the harms of prostate cancer screening in asymptomatic men outweigh the benefits. A 2013 Cochrane review found that screening asymptomatic men did not save lives from the disease, and leads to detection of indolent prostate cancers that would not have gone on to cause harm in a man’s lifetime.1 This is known as overdiagnosis. Further weight was added to the results of the Cochrane review in the recent 10-year follow-up results from the cluster randomised trial of PSA testing for prostate cancer (CAP), which found that one-off PSA testing of asymptomatic men did not save lives from prostate cancer.2

For symptomatic men, however, the clinical situation is different. Current clinical guidelines from the National Institute for Health and Care Excellence (NICE) recommend that GPs consider a PSA test and digital rectal examination (DRE) in men presenting with lower urinary tract symptoms (LUTS) to investigate suspected prostate cancer.3

For the purposes of this article we defined LUTS as: nocturia, urgency, frequency, incomplete voiding, intermittency, terminal dribble, hesitancy, straining, weak or split stream, and/or post-micturation dribble. LUTS are very common in men, and have been estimated to be present in around 80% of men aged >60 years.4

The 2013 Cochrane review stated that ‘... the presence of LUTS, typically due to benign prostatic obstruction, are very common in the ageing male and are not considered to …

View Full Text

  RCGP login

Members, please Login at RCGP to access the journal online.

  Subscriber login

Enter your BJGP login information below.

Log in using your username and password

Enter your British Journal of General Practice username.
Enter the password that accompanies your username.
Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

  Subscribe

Subscribe to the Journal - Subscribe to the print and/or online journal.

Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 68 (676)
Br J Gen Pract
Vol. 68, Issue 676
November 2018
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lower urinary tract symptoms and prostate cancer: is PSA testing in men with symptoms wise?
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
Citation Tools
Lower urinary tract symptoms and prostate cancer: is PSA testing in men with symptoms wise?
Jasmine Just, Fiona Osgun, Claire Knight
Br J Gen Pract 2018; 68 (676): 541-542. DOI: 10.3399/bjgp18X699689

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Lower urinary tract symptoms and prostate cancer: is PSA testing in men with symptoms wise?
Jasmine Just, Fiona Osgun, Claire Knight
Br J Gen Pract 2018; 68 (676): 541-542. DOI: 10.3399/bjgp18X699689
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • INTRODUCTION
    • CURRENT CLINICAL GUIDANCE
    • LUTS AND PROSTATE CANCER: WHAT IS THE EVIDENCE?
    • IMPLICATIONS FOR GENERAL PRACTICE
    • NEXT STEPS
    • CONCLUSION
    • Notes
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • The NHS England Fundamental Information Standard for Monitoring Sexual Orientation
  • Early diagnosis of lung cancer: is rapid access CT scanning the answer?
  • Tackling multimorbidity in primary care: is relational continuity the missing ingredient?
Show more Debate & Analysis

Related Articles

Cited By...

 

Influenza in the elderly

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers
  • RCGP e-Portfolio

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Blog
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44(0) 20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2019 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242